October 30, 2018

FDA: Class I recall of CyPass Micro-Stent Systems

By: Judy Mathias
Share

Editor's Note

The Food & Drug Administration (FDA) on October 24 classified Alcon Research’s recall of its CyPass Micro-Stent Systems as Class I, the most serious.

The recall was initiated because of the risk of corneal endothelial cell loss with the system, which is used in conjunction with cataract surgery for the reduction of intraocular pressure in patients with mild to moderate primary open-angle glaucoma.

Read More >>

Join our community

Learn More
Video Spotlight
Live chat by BoldChat